Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Tiapride Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,092Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    31/10/2025 Daito Pharmaceutical
    Japan
    		 Daito Co., Ltd. 222MF10276 Tiapride hydrochloride 2010-12-17 2010-12-17 326 Yokamachi, Toyama City, Toyama Prefecture
    31/10/2025 Icrom
    Italy
    		 IcromS. p. A. 218MF10085 Tiapride Hydrochloride (for manufacturing purposes only... 2006-01-27 2010-04-05 Via Delle Arti 33, 20049 Concorezzo (MI), Italy